Cancer BiologybioRxiv
A druggable addiction to de novo pyrimidine biosynthesis in diffuse midline glioma
S. PAL, J. P. Kaplan, H. Nguyen…·D. Haas-Kogan
This paper identifies a druggable metabolic vulnerability in diffuse midline glioma through a CRISPR screen, showing that inhibition of DHODH reduces pyrimidine biosynthesis and extends survival in mouse models.
DOI 10.1016/j.ccell.2022.07.012